[EN] NEW ANTIFIBRINOLYTIC COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS ANTIFIBRINOLYTIQUES
申请人:PROYECTO BIOMEDICINA CIMA SL
公开号:WO2014012964A1
公开(公告)日:2014-01-23
It relates to spirocyclic compounds of formula (I),or pharmaceutically or veterinary acceptable salts thereof, or any stereoisomers either of the compounds of formula (I) or of their pharmaceutically or veterinary acceptable salts, wherein A and B form a spirocyclic ring system wherein the spiro atom connecting A and B is a carbonatom and wherein A is a known 3- to 8-membered carbocyclic or heterocyclic monocyclic ring or a known 6- to 18-membered carbocyclic or heterocyclic polycyclic ring system; B is a known 4- to 7-membered carbocyclic or heterocyclic monocyclic ring; C is phenyl or a known 5- to 6-membered heteroaromatic ring; and R1-R7 are as defined herein. It also relates to a process for their preparation, as well as to the intermediates used in this process; to pharmaceutical or veterinary compositions containing them, and to their use in medicine, in particular as antifibrinolytic and antihemorragic agents.
这涉及到公式(I)的螺环化合物,或其在药用或兽医学上可接受的盐,或者公式(I)化合物或其药用或兽医学上可接受的盐的立体异构体,其中A和B形成一个螺环系统,其中连接A和B的螺原子是一个碳原子,A是已知的3-至8-成员碳环或杂环单环,或已知的6-至18-成员碳环或杂环多环系统;B是已知的4-至7-成员碳环或杂环单环;C是苯基或已知的5-至6-成员杂芳环;R1-R7如此定义。它还涉及到它们的制备方法,以及在该过程中使用的中间体;含有它们的药用或兽医学组合物,以及它们在医学中的用途,特别是作为抗纤溶和抗出血剂。